May 15,2018 Dear Director and The Manager of SET Re: Operating Performance’s Summary of Q1/2018 The Company has sales equivalent for the 1st quarter of last year amount to 326.04 million Baht. It has

Company's operating results in the third quarter ended September 30, 2018 has loss in amount of Baht 9.64 million (loss per share Bath 0.96), compared to the same period of last year which had loss of Baht

I - Translation - Ref : LPH/SET 2019/012 November 13, 2019 Subject : Clarification on the Operating Results for the three-month period ended September 30, 2019 (Q3/2019) To : President The Stock

Reef:020/1999 Ref : 53/2019 November 14, 2019 Subject : The explanation of operating results for the third quarter of 2019 To : The SET President Vibhavadi Medical Center Plc. would like to disclose

- Translation - Ref : LPH/SET 2020/009 May 13, 2020 Subject : Clarification on the Operating Results for the three-month period ended March 31, 2020 (Q1/2020) To : President The Stock Exchange of

statements comprise of the consolidated financial statements and the separate financial statements as compared with the financial statements for the same period in the year 2017 ended December 31, 2017. The

(0) 2661-6664 2 INDORAMA VENTURES PUBLIC CO., LTD (SET: “IVL”) MANAGEMENT DISCUSSION AND ANALYSIS (MD&A) FOR THE PERIOD OF 2Q 2017 (CONSOLIDATED) Table 1: Financial Summary - Core Financials of

investment consultant and set the period for acceptance of her re-application for approval as capital market personnel for 5 years. In this case, the period for acceptance of her re-application for approval as

consultant and set the period for acceptance of her re-application for approval as capital market personnel for 5 years. In this case, the period for acceptance of her re-application for approval as capital

, decreasing 1,242.06% compared to the same period last year due to discontinued of the Manufacturing and Distribution Agreement with PPG Coatings (Thailand) Co., Ltd has affected with long- term projects using